We help healthcare clients with their early detection and prevention of high-burden diseases, enabling them to flag patients on high-risk trajectories.
As the value of #data is being realized across the #healthcare sector, many questions are being asked on how to oversee the research and insights properly. CEO, Ori Geva, shares his thoughts on the matter. bit.ly/36kAfmV#medtech#innovation
2020 was the year that shed light on the major gaps in our #healthcare systems. With the new year comes signs of hope for the strong framework to be built with the assistance of #AdvancedAnalytics. Medial EarlySign CEO, Ori Geva, shares his thoughts: bit.ly/3oJwSNJ#AI#AI
With encouraging news of the #COVID19 vaccines, now is the time where #AI-powered predictive measures can prove highly impactful in minimizing the mark of the coronavirus. Learn more about how AI is changing the future of #medicinezd.net/3m1yhhH#MachineLearning@ZDNet
2020 was a year like no other. We are grateful that 2020 has brought out the best in us, rising to meet many #challenges and doing so with grace and dignity. From Medial Early Sign, we wish you and your loved ones a Healthy Holiday season and a #HappyNewYear! #HappyHolidays
As part of a national effort guided by @CMSGov to maximize the use of #AI in healthcare, Medial EarlySign & @GeisingerHealth are striving to find a #solution for reshaping the integration of clinical care with AI-driven insights to beneficially impact human #health.
Being chosen as a finalist to participate in stage 2 of the @CMSGov#AI Challenge is an accomplishment we are humbled to receive. Partnering with @GeisingerHealth, we are working towards reshaping the integration of clinical care with AI-driven insights to ameliorate #healthcare
The use of #AI in #healthcare comes along with various challenges. Ori Geva, CEO of Medial EarlySign, shares his thoughts on the hurdles to be overcome through participating in the CMS AI Challenge, alongside our partner @GeisingerHealth.
bit.ly/37pAHQN
CEO Ori Geva shares his thoughts on the potential impacts that Medial EarlySign, alongside our partner @GeisingerHealth, can have by participating as a finalist in stage 2 of the CMS AI Challenge. bit.ly/36pad2j#AI#medtech#healthtech
Together with @GeisingerHealth, earning finalist status in the @CMSGov#AI challenge recognizes the hard work and dedication of our joint team to pursue the larger goal of improving #health & outcomes. We look forward to what the future of this project will bring for our team!
Medial EarlySign advanced the use of #AI for leading #healthcare organizations—from providers to life sciences—to improve patient and physician experience, individualize the delivery of care, and improve outcomes. bit.ly/2IcRf62@FierceHealth#medtech
#COVID-19 has highlighted the need for change within the #healthcare sector. Many patients have avoided doctor visits due to unnecessary #infection risks, leading to many healthcare providers utilizing new #innovative solutions. Learn more: bit.ly/3izDz1H#medtech
The term #AI has been thrown a lot, but what really is #ArtificialInteligence all about? To learn more about artificial intelligence and it’s practical applications for everyday life. bit.ly/3iyoxtd#innovation
One of the biggest misconceptions surrounding #AI is that it will eventually replace doctors. At Medial EarlySign, we believe that the benefits of AI can be of assistance to doctors to better augment their abilities towards #PatientCentric#treatment. bit.ly/2RsF7ia